Atlas Trials

Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes

Clinical trial NCT02686476 · COMPLETED

Trial details

NCT number
NCT02686476
Sponsor
Medanta, The Medicity, India
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Non Alcoholic Fatty Liver Disease
Start date
2016-03-01
Primary completion
2017-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.